Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMP2.1/AS01B and FMP2.1/AS02A malaria vaccines in healthy adults
NCT00385047Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Sep 2006
- Primary completion
- Apr 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of FMP2.1/AS01B in malaria, sponsored by U.S. Army Medical Research and Development Command. Started Sep 2006; status: completed.
02
Drugs
FMP2.1/AS01B
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00385047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385047.